118 related articles for article (PubMed ID: 12130719)
1. Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate.
Ickenstein LM; Bandiera SM
J Pharmacol Exp Ther; 2002 Aug; 302(2):584-93. PubMed ID: 12130719
[TBL] [Abstract][Full Text] [Related]
2. Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen.
Kawai M; Bandiera SM; Chang TK; Poulet FM; Vancutsem PM; Bellward GD
Drug Metab Dispos; 1999 Dec; 27(12):1392-8. PubMed ID: 10570019
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Dipippo VA; Powers CA
J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491
[TBL] [Abstract][Full Text] [Related]
4. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen alters hepatic cytochrome P450 enzyme expression and circulating growth hormone levels in intact male rats.
Ickenstein LM; Holsmer SL; Bandiera SM
Pharm Res; 2004 Sep; 21(9):1631-6. PubMed ID: 15497689
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.
Fitts JM; Klein RM; Powers CA
J Pharmacol Exp Ther; 1998 Jul; 286(1):392-402. PubMed ID: 9655884
[TBL] [Abstract][Full Text] [Related]
7. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
8. Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.
Nuwaysir EF; Dragan YP; Jefcoate CR; Jordan VC; Pitot HC
Cancer Res; 1995 Apr; 55(8):1780-6. PubMed ID: 7712488
[TBL] [Abstract][Full Text] [Related]
9. Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone.
Ram PA; Waxman DJ
Mol Endocrinol; 1991 Jan; 5(1):13-20. PubMed ID: 2017188
[TBL] [Abstract][Full Text] [Related]
10. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
Reed CA; Berndtson AK; Nephew KP
Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
[TBL] [Abstract][Full Text] [Related]
13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
14. Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
DiPippo VA; Lindsay R; Powers CA
Endocrinology; 1995 Mar; 136(3):1020-33. PubMed ID: 7867556
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
Moon LY; Wakley GK; Turner RT
Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
17. Induction of hepatic CYP2B is a more sensitive indicator of exposure to aroclor 1260 than CYP1A in male rats.
Ngui JS; Bandiera SM
Toxicol Appl Pharmacol; 1999 Dec; 161(2):160-70. PubMed ID: 10581210
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic treatment with thyroxine and estradiol on estrogen concentration in serum and on hepatic microsomal catechol estrogen formation in female rats.
Shiverick KT; Delorme AM; Scammell JG; Fregly MJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):564-9. PubMed ID: 7086671
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
Waxman DJ; Ram PA; Pampori NA; Shapiro BH
Mol Pharmacol; 1995 Nov; 48(5):790-7. PubMed ID: 7476908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]